Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
4.660
-0.110 (-2.31%)
At close: Jul 30, 2025, 4:00 PM
4.660
0.00 (0.00%)
After-hours: Jul 30, 2025, 4:00 PM EDT
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $590.50 million as of July 30, 2025. Its market cap has increased by 53.06% in one year.
Market Cap
590.50M
Enterprise Value
540.30M
1-Year Change
53.06%
Ranking
Category
Stock Price
$4.66
Market Cap Chart
Since January 5, 2017, Organogenesis Holdings's market cap has increased from $376.60M to $590.50M, an increase of 56.80%. That is a compound annual growth rate of 5.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 605.10M | 42.64% |
| Dec 31, 2024 | 424.20M | -21.44% |
| Dec 29, 2023 | 540.00M | 53.32% |
| Dec 30, 2022 | 352.20M | -70.37% |
| Dec 31, 2021 | 1.19B | 46.45% |
| Dec 31, 2020 | 811.60M | 78.10% |
| Dec 31, 2019 | 455.70M | 30.13% |
| Dec 31, 2018 | 350.20M | -8.90% |
| Dec 29, 2017 | 384.40M | 2.07% |
| Jan 5, 2017 | 376.60M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.67B |
| Johnson & Johnson | 405.78B |
| AbbVie | 336.62B |
| UnitedHealth Group | 238.58B |
| AstraZeneca | 230.79B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 224.54B |
| Novo Nordisk | 221.96B |